JAMA ophthalmology۲۰۲۵۶۸ استنادنمایه شده در PubMed
Bradley J Katz, Michael S Lee, Norah S Lincoff, Anne S Abel, Somya Chowdhary, Brian D Ellis, Ahmad Najafi, John Nguyen, Meagan D Seay, Judith E A Warner
چکیده
Nearly 2% of the US population received a prescription for semaglutide in 2023. There has been a recent concern that this drug and other similar medications may be associated with ophthalmic complications. To report ophthalmic complications associated with the use of semaglutide or tirzepatide.…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1001/jamaophthalmol.2024.6058